B. Metzler seel. Sohn & Co’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $382K | Buy |
1,581
+319
| +25% | +$77K | ﹤0.01% | 672 |
|
|
2025
Q1 | $307K | Hold |
1,262
| – | – | ﹤0.01% | 691 |
|
|
2024
Q4 | $415K | Hold |
1,262
| – | – | ﹤0.01% | 668 |
|
|
2024
Q3 | $422K | Hold |
1,262
| – | – | ﹤0.01% | 664 |
|
|
2024
Q2 | $345K | Buy |
1,262
+180
| +17% | +$49.2K | ﹤0.01% | 677 |
|
|
2024
Q1 | $374K | Hold |
1,082
| – | – | ﹤0.01% | 657 |
|
|
2023
Q4 | $349K | Sell |
1,082
-9
| -0.8% | -$2.91K | ﹤0.01% | 651 |
|
|
2023
Q3 | $391K | Hold |
1,091
| – | – | 0.01% | 611 |
|
|
2023
Q2 | $414K | Hold |
1,091
| – | – | 0.01% | 603 |
|
|
2023
Q1 | $523K | Hold |
1,091
| – | – | 0.01% | 550 |
|
|
2022
Q4 | $459K | Buy |
1,091
+55
| +5% | +$23.1K | 0.01% | 571 |
|
|
2022
Q3 | $432K | Buy |
1,036
+229
| +28% | +$95.5K | 0.01% | 564 |
|
|
2022
Q2 | $399K | Hold |
807
| – | – | 0.01% | 591 |
|
|
2022
Q1 | $455K | Hold |
807
| – | – | 0.01% | 617 |
|
|
2021
Q4 | $612K | Sell |
807
-511
| -39% | -$388K | 0.01% | 517 |
|
|
2021
Q3 | $983K | Buy |
1,318
+580
| +79% | +$433K | 0.01% | 441 |
|
|
2021
Q2 | $475K | Sell |
738
-81
| -10% | -$52.1K | 0.01% | 558 |
|
|
2021
Q1 | $468K | Buy |
819
+229
| +39% | +$131K | 0.01% | 560 |
|
|
2020
Q4 | $339K | Buy |
+590
| New | +$339K | 0.01% | 584 |
|